Complement Inhibition for the Treatment of Myasthenia Gravis

Generalized myasthenia gravis (gMG) is a rare autoimmune disorder affecting the neuromuscular junction (NMJ). Approximately 80–90% of patients display antibodies directed against the nicotinic acetylcholine receptor (AChR). A major drive of AChR antibody-positive MG pathology is represented by compl...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Immunotargets Ther
Main Authors: Mantegazza, Renato, Vanoli, Fiammetta, Frangiamore, Rita, Cavalcante, Paola
Format: Artigo
Jezik:Inglês
Izdano: Dove 2020
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7751298/
https://ncbi.nlm.nih.gov/pubmed/33365280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S261414
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki